|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:approves
|
gptkb:2003
gptkb:FDA
|
|
gptkbp:brand
|
gptkb:Lybrel
Yaz
Seasonique
|
|
gptkbp:class
|
gptkb:drug
|
|
gptkbp:clinical_trial
|
efficacy studies
Phase III trials
safety studies
|
|
gptkbp:contains
|
gptkb:ethinyl_estradiol
gptkb:levonorgestrel
|
|
gptkbp:contraindication
|
liver disease
smoking
certain cancers
history of blood clots
|
|
gptkbp:dosage_form
|
gptkb:tablet
0.03 mg ethinyl estradiol
0.15 mg levonorgestrel
|
|
gptkbp:duration
|
28 days
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Seasonale
|
|
gptkbp:ingredients
|
gptkb:ethinyl_estradiol
gptkb:levonorgestrel
|
|
gptkbp:interacts_with
|
gptkb:St._John's_Wort
antibiotics
anticonvulsants
|
|
gptkbp:is_effective_against
|
over 99% with perfect use
91% with typical use
|
|
gptkbp:is_used_for
|
birth control
|
|
gptkbp:manager
|
oral
|
|
gptkbp:manufacturer
|
gptkb:physicist
|
|
gptkbp:marketed_as
|
gptkb:Seasonale
|
|
gptkbp:packaging
|
blister pack
|
|
gptkbp:previous_name
|
ethinyl estradiol and levonorgestrel
|
|
gptkbp:release_region
|
gptkb:government_agency
gptkb:Australia
gptkb:Brazil
gptkb:India
gptkb:Japan
gptkb:Mexico
gptkb:Monarch
gptkb:United_Kingdom
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:requires
|
gptkb:theorem
|
|
gptkbp:scholarships
|
consult healthcare provider
|
|
gptkbp:side_effect
|
headache
nausea
weight gain
breast tenderness
mood changes
|
|
gptkbp:symptoms
|
irregular bleeding
amenorrhea
|
|
gptkbp:bfsParent
|
gptkb:ethinylestradiol
|
|
gptkbp:bfsLayer
|
6
|